A protein known for burning fat, hormone-sensitive lipase (HSL), has been found to control fat cell health from inside the nucleus. This discovery challenges previous understandings of obesity and metabolic diseases. Scientists previously believed HSL primarily released stored fat for energy.
Researchers at the Université de Toulouse found HSL operating deep inside the nucleus of fat cells. The nucleus stores deoxyribonucleic acid (DNA) and controls genetic activity. This finding reveals a new function for a protein studied since the 1960s.
The research, published in *Cell Metabolism*, helps explain a long-standing mystery in obesity research. It also opens new avenues for understanding diabetes, heart disease, and other metabolic disorders. Fat cells, or adipocytes, are not merely storage units; they actively regulate the body's energy system.
HSL's role in the nucleus appears to involve regulating mitochondrial activity and the extracellular matrix. Mitochondria generate cellular energy. The extracellular matrix provides structural support for tissues. Problems in these systems are linked to obesity, inflammation, and metabolic disease.
Studies of mice and humans lacking HSL showed they developed lipodystrophy, a condition of dangerous fat tissue loss, instead of obesity. This suggests that HSL's nuclear function is crucial for maintaining healthy fat tissue. The amount of nuclear HSL changes with the body's metabolic state.
This discovery suggests that future therapies for metabolic diseases may focus on restoring fat cell function. They may also protect the biological systems that maintain healthy fat tissue. Understanding how proteins like HSL regulate fat cell health could lead to more targeted treatments.
Related stories
Dreaming May Deplete Brain Energy Despite Increased Fuel Supply
New research indicates that dreaming during REM sleep may consume significant brain energy, with neuronal energy levels dropping despite an increase in the brain's fuel supply.
Tirzepatide May Activate Calorie-Burning Brown Fat
A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, may activate calorie-burning brown fat, offering a new understanding of its metabolic benefits.
ADHD and Autism Diagnoses Show Shifting Demographics in Denmark
A large Danish study found that children diagnosed with ADHD or autism now more closely resemble the general population, suggesting broader identification rather than only an increase in underlying conditions.